No IPOs are currently scheduled in the week ahead, although smaller issuers may join the calendar throughout the week. Read ...
To support tenants using AI, life sciences buildings need increased slab loads, electricity and water, all expensive upgrades for owners.
The final report, presented to New York Governor Kathy Hochul, outlines a path to translate investments in the state's biotech ecosystem into real-world outcomes. -- Executives from The Michael J. Fox ...
Since its inception, Aktis Oncology has raised roughly $346 million, including a $175 million Series B funding round in 2024, from life sciences institutional investors such as MPM BioImpact, Vida ...
At a recent summit, several corporate CEOs expressed optimism about the year ahead, though they noted some concerns about U.S. economic security and technological support.
Credits: Anna Tutova(Founder AI Crypto Minds) with Peter Diamandis(Founder XPRIZE Foundation). In this interview withPeter ...
Motley Fool co-founder and CEO Tom Gardner closes out 2025 with a big-picture look at what's driven the market's strong run, why enthusiasm can push valuations too high, and how investors can stay ...
With all the buzzwords surrounding artificial intelligence, from smiling promotions to angry chagrins—promises that it will ...
In part two of NJBIZ’s interview, BioNJ CEO Debbie Hart discusses policy, AI, manufacturing and what’s next for New Jersey life sciences.
Merck & Co. is turning down its option to license Evaxion’s gonorrhea vaccine candidate, closing the door on the Danish ...
China figured out how to sell EVs. Now it has to bury their batteries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback